Resources
About Us
Home Report
Store
Next Generation Sequencing (NGS) Market
Next Generation Sequencing (NGS) Market by Offering (Kits [Library Prep, QC, DNA Extraction], System) Type (Genome, Exome, Targeted) Application (Reproductive, Oncology, Infectious) Technology (SBS, Nanopore, Nanoball, SMRT Seq) – Global Forecast to 2030
Report ID:MRHC - 104342 Pages: 317 Jun-2023 Formats*: PDF Category: Healthcare Delivery: 2 to 4 HoursThe Next Generation Sequencing (NGS) Market is expected to reach $27.5 billion by 2030, at a CAGR of 15.8% from 2023–2030. The growth of the NGS market is mainly attributed to increasing cancer prevalence & increasing application of NGS in cancer treatment and research, declining cost of genome sequencing, technological advancements in sequencing procedures, increasing pharmaceutical R&D expenditure, a surge in genome mapping programs, improvement in regulatory and reimbursement scenarios for NGS–based diagnostic tests.
However, the high costs of NGS systems and associated consumables, availability of alternative technologies, low chances of identifying positive, actionable mutations for precision medicine, and ethical & legal issues related to NGS–based diagnosis are restraints to the market's growth. Increasing applications of NGS, rising adoption of bioinformatics and genomic data management solutions, and government initiatives for large-scale genomic sequencing projects are opportunities leading to the market's growth. However, the lack of skilled professionals and regulatory and standardization concerns in diagnostic testing are challenges to the growth of the NGS market. Also, partnerships and collaborations by manufacturers to expand and improve product offerings, development of portable sequencing technologies, and increasing demand for NGS automation workstations are trends in the NGS market.
Partnerships and Collaborations by Manufacturers Triggering New Application Developments in the NGS Market
With rapid advancements in NGS technology, key players in this market actively collaborate to transform patients‘ lives by providing appropriate genetic variation and function analysis and ultimately delivering personalized healthcare. Many of these collaborations aim to improve bioinformatics and enhance technological capabilities for developing innovative products and solutions.:
• In January 2023, QIAGEN partnered with Helix OpCo, LLC (U.S.), a population genomics and viral surveillance company. This partnership will trigger the adoption of next-generation sequencing companion diagnostics in hereditary diseases.
• In March 2023, QIAGEN partnered with SOPHiA GENETICS (U.S.) to combine Next Generation Sequencing (NGS) strengths. This partnership will give customers an advantage over high-quality QIAGEN NGS preparation kits.
• In November 2022, Illumina partnered with Twist Bioscience (U.S.) to produce an Exome 2.0 Plus panel for disease research. Through this partnership, Illumina will offer the Exome 2.0 Plus panel with its DNA library preparation reagents packaged as a kit.
• In February 2022, Beckman Coulter, Inc. (U.S.) collaborated with Illumina, Inc. (U.S.) to develop new applications for the Biomek NGeniuS System. Illumina will develop applications specifically designed for the Biomek NGeniuS liquid handler.
• In November 2021, Beckman Coulter, Inc. (U.S.) collaborated with Integrated DNA Technologies, Inc. (U.S.) to develop new applications for the Biomek NGeniuS System. Integrated DNA Technologies aims to make its NGS solutions more accessible to a broader array of labs by automating its NGS solutions on the Biomek NGeniuS System.
• In September 2021, Beckman Coulter, Inc. (U.S.) collaborated with Invitae Corporation (U.S.) to develop new applications for the Biomek NGeniuS System.
• In June 2021, QIAGEN N.V. (Germany) collaborated with Verogen Inc. (U.S.) to accelerate the automation of NGS library prep kits and expand the Biomek NGenuiS liquid handler applications. Also, through this collaboration, both companies cooperate to commercialize a broad menu of forensically validated workflows for NGS by combining QIAGEN’s QIAseq products with Verogen’s library preparation products, expertise, and automation solutions.
• In February 2021, Thermo Fisher Scientific partnered with SPT Labtech Ltd (U.K.). Through this partnership, SPT Labtech will co-market Thermo Fisher’s NGS library preparation products, further reducing Thermo Fisher’s material and reagent requirements for high throughput genome sequencing.
Thus, increasing collaborations among vendors are expected to accelerate the adoption of the NGS technology.
-Market.webp "Next Generation Sequencing (NGS) Market")
Click here to: Get Free Sample Pages of this Report
Development of Portable Sequencing Technologies is Creating Significant Opportunities for The Market Growth
The ability to sequence genes of any organism to make clinical and research conclusions has proved to be a game changer for public health. Taking this forward, portable handheld sequencing devices are making way for the future growth of this market by making sequencing cheaper, simpler, and faster without the need for big clinical laboratories. Real-time sequencing has enabled researchers and physicians to have sequencing data on the spot and act instantly. The portable nanopore-based sequencers are designed with the potential to sequence the entire genome in less than USD 1,000. The device passes the DNA sequence through a pore within a small protein called the nanopore that is embedded within a membrane. The DNA molecule then passes through the nanopore connecting the template and the ―complementary strand with the adaptor. The connection of the strands with the adaptor initiates an electric current, which is typically recorded and represented in the form of a graph.
Real-time sequencing is now slowly being adopted in disease characterization, food, and healthcare industry to detect contaminants, plant genome analysis in crop processing, and more. For instance, Boston-based biotech company Ginkgo Bioworks used a MinION nanopore sequencing device to detect the toxic contaminants in the culture and alerted the operators to remove toxic components, thus, saving the culture. Also, the scientists in Madagascar, for the first time, performed DNA sequencing in the country using portable technology to rapidly identify the bacteria responsible for tuberculosis (TB) and its drug resistance profile.
Also, recently portable sequencing devices were proven useful for the early detection of Ebola and Zika viruses. According to Cornell University (U.S.), portable sequencing offers various advantages over benchtop sequencers. Portable sequencers are inexpensive, mobile, handy, and designed to be easily operable in the field. Moreover, they use the biochemical principle, which enables real-time streaming of the raw signal as soon as the DNA molecules are sensed.
Key Findings of the NGS Market Study:
Among Offerings, in 2023, the Consumables Segment is Estimated to Account for the Largest Share of the Market
The global NGS market is segmented into consumables, NGS platforms/instruments, software, and services. In 2023, the consumables segment is expected to account for the largest share of the global NGS market. The large market share of this segment is attributed to recurring demand for consumables and the rising adoption of NGS technology for clinical and research purposes.
The Targeted Genome Sequencing Segment is Estimated to Account for the Largest Share of the Market
Based on sequencing type, the global NGS market is segmented into targeted genome sequencing, whole genome sequencing, whole exome sequencing, and other sequencing types. In 2023, the targeted genome sequencing segment is expected to account for the larger share of the global NGS market. The large market share of this segment is attributed to low sequencing costs compared to other sequencing technologies, higher sensitivity of the technique to call variants, and proven results in identifying primary immunodeficiencies and specific gene-associated diseases.
In 2023, the Sequencing by Synthesis Segment is Estimated to Account for the Largest Share of the Market
Based on technology, the global NGS market is segmented into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing (SMRT), nanopore sequencing, and DNA nanoball sequencing. In 2023, the sequencing by synthesis segment is expected to account for the largest share of the global NGS market. The key factors supporting the large market share of this segment are highly accurate output with base-by-base sequencing using sequencing by synthesis, reducing sequence-specific errors and enabling robust base calling across the entire genome, including repetitive sequences and homopolymers.
The Research and Other Applications Segment is Estimated to Account for the Largest Share of the Market
Based on application, the research and other applications segment is estimated to account for the largest share of the market. Increasing applications of NGS in research for oncology, agriculture and other research, rising advantages about the advantages of genetic research and testing using NGS technology, and increasing cancer cases are some of the factors expected to account for the largest share of research and other applications segment.
The Pharmaceutical & Biotechnology Companies Segment is Estimated to Account for the Largest Share of the NGS Market in 2023
The large share of this segment is primarily attributed to the increasing adoption of advanced technologies for research purposes, the availability of capital, and increasing research for drug discovery with widening NGS applications, thereby accounting for the largest share of the market.
Asia-Pacific: Fastest Growing Regional Market
Asia-Pacific is expected to grow at the highest CAGR during the forecast period. The growth of the NGS market in this region is the growing demand for NGS-based diagnosis, the rising inclination of healthcare professionals for NGS data for treatment purposes, and the increasing prevalence of cancer. Additionally, increasing demand for NGS in Japan and China, rising government focus on genetic diseases, and the growing number of research institutions demanding NGS technology for multiple applications also support the market's growing share.
Key Players
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over the years.The key players operating in the global NGS market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer, Inc. (U.S.), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), 10X Genomics, Inc. (U.S.), and Beijing Genomics Institute (BGI) (China).
Scope of the Report:
NGS Market Assessment, By Offering
- Consumables
- Sample Preparation Consumables
- DNA Extraction and Amplification
- Library Preparation & Target Enrichment
- Quality Control
- Other Consumables
- Sample Preparation Consumables
- NGS Platforms/Instruments
- Software
- Services
(Other consumables include vials, pipettes, containers, trays, sequencing reagents, flow cells, and tubes)
NGS Market Assessment, by Sequencing Type
- Targeted Genome Sequencing
- Whole Genome Sequencing
- Whole Exome Sequencing
- Other Sequencing Types
(Other sequencing types include degradome sequencing, chromatin immunoprecipitation (ChIP) sequencing, and methylation sequencing)
NGS Market Assessment, by Technology
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Single-molecule Real-time Sequencing (SMRT)
- Nanopore Sequencing
- DNA nanoball sequencing
NGS Market Assessment, by Application
- Research Applications
- Drug Discovery
- Agriculture & Animal Research
- Other Research Applications
- Clinical Applications
- Reproductive Health Diagnosis
- Oncology
- Infectious Diseases
- Other Clinical Applications
(Other research applications include food microbiology, microbiota analysis in the beverage industry, and environmental studies, and other clinical applications include the detection of genetic aberrations in neurological disorders, rare diseases, metabolic and immune disorders, and food-borne illnesses)
NGS Market Assessment, by End User
- Hospitals and Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Academic Institutes & Research Centers
- Other End Users
(Other end users include forensic laboratories & security agencies, food & beverage companies, and agriculture companies)
NGS Market Assessment, by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of Asia-Pacific (RoAPAC)
- Latin America
- Brazil
- Mexico
- Rest of Latin America (RoLATAM)
- Middle East & Africa
Key questions answered in the report:
The global NGS market is segmented by Offering (Consumables [Sample Preparation Consumables {DNA Extraction and Amplification, Library Preparation & Target Enrichment, Quality Control}, Other Consumables], NGS Platforms/Instruments, Software, Services), Sequencing Type (Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Other Sequencing Types), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing (SMRT), Nanopore Sequencing, DNA Nanoball Sequencing), Applications (Clinical Applications [Reproductive Health, Oncology, Infectious Diseases, Other Clinical Applications], Research and Other Applications [Drug Discovery, Agriculture & Animal Research, Other Research Applications), End User (Hospitals and Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic Institutes & Research Centers, Other End Users), and Geography. The global NGS market studied in this report involves the value analysis of various segments of NGS at regional and country levels.
The global NGS market is projected to reach $27.5 billion by 2030, at a CAGR of 15.8% during the forecast period.
The consumables segment is estimated to account for the largest share of the NGS market in 2023. The recurring use of consumables, rising adoption of NGS by pharmaceutical and biotechnology companies, increasing cases of cancer and other chronic diseases and the rising cult of healthcare professionals for NGS-based tests for treatment purposes is increasing the use of consumables.
Based on the sequencing type, the targeted genome sequencing segment is projected to create more demand, owing to highly accurate results, increasing demand for targeted genome sequencing, and low cost with high reliability.
Based on technology, the sequencing by synthesis segment is projected to create more traction during the forecast period due to the growing incorporation of this technology in NGS products, the highest yield of error-free throughput, and the high accuracy of this technology in DNA sequencing.
The research application segment is estimated to account for the largest share of the NGS market in 2023. Factors include increasing applications of NGS in treating chronic diseases such as cardiovascular diseases, cancer, and genetic diseases. The increase in genome mapping programs and the focus of key players on supporting affordable NGS instruments are responsible for the largest share of the segment.
Based on end user, the hospitals and diagnostic laboratories segment is projected to create more traction during the forecast period due to an increasing patient inflow in the hospital and diagnostic laboratories, more well-established infrastructure, and technological advancements.
The growth of the global NGS market is rising cancer prevalence and increasing application of NGS in cancer treatment and research, the declining costs of genome sequencing, technological advancements in sequencing procedures, increasing pharmaceutical R&D expenditures, the surge in genome mapping programs, and improvements in regulatory and reimbursement scenarios for NGS-based diagnostic tests.
The key players operating in the global NGS market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer, Inc. (U.S.), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), 10X Genomics, Inc. (U.S.), and Beijing Genomics Institute (BGI) (China).
The emerging Asian-Pacific countries are projected to offer significant growth opportunities for the vendors in this market due to the growing demand for NGS-based diagnostic tests, rising healthcare expenditure, increasing investments by healthcare providers towards infrastructure improvement, and growing accessibility of advanced healthcare services & products.
1. Overview
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency And Limitation
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research / Interviews with Key Opinion Leaders of The Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions For the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.2. Factor Analysis
4.3. Trends
4.3.1. Industry Trends
4.3.1.1. Increasing Partnerships and Collaborations among NGS Instrument Manufacturers to Expand and Improve Product Offerings
4.3.2. Technology Trends
4.3.2.1. Development of Portable Sequencing Technologies
4.3.2.2. Increasing Demand for NGS Automation
4.4. Case Studies
4.4.1. Clear Labs, Inc. (U.S.) Offers Google Cloud Services-based NGS Platform for Food Safety Testing
4.4.2. Pairend Biotechnology (Turkey) Offers NGS Cloud, an Artificial Intelligence-Supported Genetic Data Analysis Platform
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Buyers
4.5.2. Bargaining Power of Suppliers
4.5.3. Threat of Substitutes
4.5.4. Threat of New Entrants
4.5.5. Degree of Competition
4.6. Pricing Analysis
5. Next-Generation Sequencing (NGS) Market: Regulatory Analysis
5.1. Introduction
5.2. North America
5.2.1. U.S.
5.2.2. Canada
5.3. Europe
5.4. Asia-Pacific
5.4.1. China
5.4.2. Japan
5.4.3. India
5.5. Latin America
5.6. Middle East
6. Next Generation Sequencing (NGS) Market Assessment—by Offering
6.1. Overview
6.2. Consumables
6.2.1. Sample Preparation Consumables
6.2.1.1. DNA Extraction and Amplification
6.2.1.2. Library Preparation & Target Enrichment
6.2.1.3. Quality Control
6.2.2. Other Consumables
6.3. NGS Platforms/Instruments
6.4. Software
6.5. Services
7. Global Next Generation Sequencing (NGS) Market Assessment–by Sequencing Type
7.1. Overview
7.2. Targeted Genome Sequencing
7.3. Whole Genome Sequencing
7.4. Whole Exome Sequencing
7.5. Other Sequencing Types
8. Global Next-Generation Sequencing (NGS) Market Assessment–by Technology
8.1. Overview
8.2. Sequencing by Synthesis
8.3. Ion Semiconductor Sequencing
8.4. Single-Molecule Real-Time Sequencing (SMRT)
8.5. Nanopore Sequencing
8.6. DNA Nanoball (DNB) Sequencing
9. Next-Generation Sequencing (NGS) Market Assessment–by Application
9.1. Overview
9.2. Research and Other Applications
9.2.1. Drug Discovery
9.2.2. Agriculture & Animal Research
9.2.3. Other Research Applications
9.3. Clinical Applications
9.3.1. Reproductive Health
9.3.2. Oncology
9.3.3. Infectious Diseases
9.3.4. Other Clinical Applications
10. Global Next-Generation Sequencing (NGS) Market Assessment–by End User
10.1. Overview
10.2. Pharmaceutical & Biotechnology Companies
10.3. Hospitals And Diagnostic Laboratories
10.4. Academic Institutes & Research Centers
10.5. Other End Users
11. Next-Generation Sequencing (NGS) Market Assessment—by Geography
11.1. Overview
11.2. North America
11.2.1. U.S.
11.2.2. Canada
11.3. Europe
11.3.1. Germany
11.3.2. France
11.3.3. U.K.
11.3.4. Italy
11.3.5. Spain
11.3.6. Rest of Europe
11.4. Asia-Pacific
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Rest of Asia-Pacific (RoAPAC)
11.5. Latin America
11.5.1. Brazil
11.5.2. Mexico
11.5.3. Rest of Latin America
11.6. Middle East & Africa
12. Competition Analysis
12.1. Overview
12.2. Key Growth Strategies
12.3. Competitive Benchmarking
12.4. Market Share Analysis (2022)
12.4.1. Illumina, Inc. (U.S.)
12.4.2. Thermo Fisher Scientific Inc. (U.S.)
12.4.3. Beijing Genomics Institute (BGI) (China)
12.5. Competitive Dashboard
12.5.1. Industry Leaders
12.5.2. Market Differentiators
12.5.3. Vanguards
12.5.4. Emerging Companies
13. Company Profiles (Business Overview, Financial Overview, Product Portfolio, SWOT Analysis of Top 5 Companies, and Strategic Developments)
13.1. Thermo Fisher Scientific, Inc.
13.2. Illumina, Inc.
13.3. Qiagen N.V.
13.4. F. Hoffmann-La Roche Ltd
13.5. Perkinelmer, Inc.
13.6. Agilent Technologies, Inc.
13.7. Pacific Biosciences of California, Inc.
13.8. Danaher Corporation
13.9. Bio-Rad Laboratories, Inc.
13.10. Oxford Nanopore Technologies Plc.
13.11. 10X Genomics, Inc.
13.12. Beijing Genomics Institute (BGI)
14. Appendix
14.1. Available Customization
14.2. Related Reports
List of Tables
Table 1 Global NGS Market: Impact Analysis of Market Dynamics (2023–2030)
Table 2 Estimated Number of New Cancer Cases, by Type (2020 Vs. 2030)
Table 3 Incidence of Common Genetic Disorders
Table 4 Genome Sequencing Costs (2010–2021)
Table 5 Portable Sequencers Vs. Benchtop Sequencers
Table 6 NGS Instruments Price List
Table 7 NGS Consumables Price List
Table 8 Regulatory Authorities Governing In Vitro Diagnostics & NGS Products, by Country/Region
Table 9 NGS Software: Standards and Compliance Guidelines
Table 10 Global NGS Market, by Offering, 2021–2030 (USD Million)
Table 11 Global NGS Consumables Market, by Type, 2021–2030 (USD Million)
Table 12 Global NGS Consumables Market, by Country/Region, 2021–2030 (USD Million)
Table 13 Global NGS Sample Preparation Consumables Market, by Type, 2021–2030(USD Million)
Table 14 Global NGS Sample Preparation Consumables Market, by Country/Region, 2021-2030 (USD Million)
Table 15 Global NGS DNA Extraction and Amplification Consumables Market, by Country/Region, 2021–2030 (USD Million)
Table 16 Global NGS Library Preparation & Target Enrichment Consumables Market, by Country/Region, 2021-2030 (USD Million)
Table 17 Global NGS Quality Control Consumables Market, by Country/Region, 2021-2030 (USD Million)
Table 18 Global Other NGS Consumables Market, by Country/Region, 2021-2030 (USD Million)
Table 19 Some of The Companies Offering NGS Instruments
Table 20 Global NGS Platforms/Instruments Market, by Country/Region, 2021–2030 (USD Million)
Table 21 Key Players Offering NGS Software
Table 22 Global NGS Software Market, by Country/Region, 2021-2030 (USD Million)
Table 23 Key Players Offering NGS Services
Table 24 Global NGS Services Market, by Country/Region, 2021-2030 (USD Million)
Table 25 Global NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 26 Global NGS Market for Targeted Genome Sequencing, by Country/Region, 2021–2030 (USD Million)
Table 27 Global NGS Market for Whole Genome Sequencing, by Country/Region, 2021–2030 (USD Million)
Table 28 Global NGS Market for Whole Exome Sequencing, by Country/Region, 2023–2030 (USD Million)
Table 29 Global NGS Market for Other Sequencing Types, by Country/Region, 2021–2030 (USD Million)
Table 30 GLOBAL NGS Market, by Technology, 2021–2030 (USD Million)
Table 31 Global NGS Market for Sequencing by Synthesis, by Country/Region, 2021–2030 (USD Million)
Table 32 Global NGS Market for Ion Semiconductor Sequencing, by Country/Region, 2021–2030 (USD Million)
Table 33 Global NGS Market for Single-Molecule Real-Time Sequencing, by Country/Region, 2021–2030 (USD Million)
Table 34 Global NGS Market for Nanopore Sequencing, by Country/Region, 2021–2030 (USD Million)
Table 35 Global NGS Market for DNA Nanoball (DNB) Sequencing, by Country/Region, 2021–2030 (USD Million)
Table 36 Global NGS Market, by Application, 2021–2030 (USD Million)
Table 37 Global NGS Market for Research and Other Applications, by Type 2021–2030 (USD Million)
Table 38 Global NGS Market for Research and Other Applications, by Country/Region, 2021–2030 (USD Million)
Table 39 Global NGS Market for Drug Discovery, by Country/Region, 2021–2030 (USD Million)
Table 40 Global NGS Market for Agriculture & Animal Research, by Country/Region, 2021–2030 (USD Million)
Table 41 Global NGS Market for Other Research Applications, by Country/Region, 2021–2030 (USD Million)
Table 42 Global NGS Market for Clinical Applications, by Type 2021–2030 (USD Million)
Table 43 Global NGS Market for Clinical Applications, by Country/Region, 2021–2030 (USD Million)
Table 44 Global NGS Market for Reproductive Health, by Country/Region, 2021–2030 (USD Million)
Table 45 Currently Available Targeted Therapies and Corresponding Biomarkers
Table 46 Global NGS Market for Oncology, by Country/Region, 2021–2030 (USD Million)
Table 47 HIV Prevalence Among Adults, by Region (2020 Vs. 2021)
Table 48 Global NGS Market for Infectious Diseases, by Country/Region, 2021–2030 (USD Million)
Table 49 Global NGS Market for Other Clinical Applications, by Country/Region, 2021–2030 (USD Million)
Table 50 Global NGS Market, by End User, 2021–2030 (USD Million)
Table 51 Global Pharmaceutical R&D Spending, 2012–2026 (USD Billion)
Table 52 Global NGS Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2021–2030 (USD Million)
Table 53 Global NGS Market for Hospitals and Diagnostic Laboratories, by Country/Region, 2021–2030 (USD Million)
Table 54 Global NGS market for Academic Institutes & Research Centers, by Country/Region, 2021–2030 (USD Million)
Table 55 Global NGS Market for Other End Users, by Country/Region, 2021–2030 (USD Million)
Table 56 Global NGS Market, by Country/Region, 2021–2030 (USD Million)
Table 57 North America: NGS Market, by Country, 2021–2030 (USD Million)
Table 58 North America: NGS Market, by Offering, 2021–2030 (USD Million)
Table 59 North America: NGS Consumables Market, by TYPE, 2021–2030 (USD Million)
Table 60 North America: NGS Sample Preparation Consumables Market, by Type, 2021–2030 (USD Million)
Table 61 North America: NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 62 North America: NGS Market, by Technology, 2021–2030 (USD Million)
Table 63 North America: NGS Market, by Application, 2021–2030 (USD Million)
Table 64 North America: NGS Market for Clinical Applications, by Type, 2021–2030 (USD Million)
Table 65 North America: NGS Market for Research Applications, by Type, 2021–2030 (USD Million)
Table 66 North America: NGS Market, by End User, 2021–2030 (USD Million)
Table 67 U.S.: Key Macro & Microindicators
Table 68 U.S.: NGS Market, by Offering, 2021–2030 (USD Million)
Table 69 U.S.: NGS Consumables Market, by Type, 2021–2030 (USD Million)
Table 70 U.S.: NGS Sample Preparation Consumables Market, by Type, 2021–2030 (USD Million)
Table 71 U.S.: NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 72 U.S.: NGS Market, by Technology, 2021–2030 (USD Million)
Table 73 U.S.: NGS Market, by Application, 2021–2030 (USD Million)
Table 74 U.S.: NGS Market for Clinical Applications, by Type, 2021–2030 (USD Million)
Table 75 U.S.: NGS Market, for Research Applications, by Type, 2021–2030 (USD Million)
Table 76 U.S.: NGS Market, by End User, 2021–2030 (USD Million)
Table 77 Canada: Key Macro & Micro Indicators
Table 78 Canada: NGS Market, by Offering, 2021–2030 (USD Million)
Table 79 Canada: NGS Consumables Market, by Type (USD Million)
Table 80 Canada: NGS Sample Preparation Consumables Market, by Type, 2021–2030 (USD Million)
Table 81 Canada: NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 82 Canada: NGS Market, by Technology, 2021–2030 (USD Million)
Table 83 Canada: NGS Market, by Application, 2021–2030 (USD Million)
Table 84 Canada: NGS Market, for Clinical Applications, by Type, 2021–2030 (USD Million)
Table 85 Canada: NGS Market, for Research Applications, by Type, 2021–2030 (USD Million)
Table 86 Canada: NGS Market, by End User, 2021–2030 (USD Million)
Table 87 Europe: NGS Market, by Country, 2021–2030 (USD Million)
Table 88 Europe: NGS Market, by Offering, 2021–2030 (USD Million)
Table 89 Europe: NGS Consumables Market, by Type, 2021–2030 (USD Million)
Table 90 Europe: NGS Sample Preparation Consumables Market, by Type, 2021–2030 (USD Million)
Table 91 Europe: NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 92 Europe: NGS Market, by Technology, 2021–2030 (USD Million)
Table 93 Europe: NGS Market, by Application, 2021–2030 (USD Million)
Table 94 Europe: NGS Market, for Clinical Applications, by Type, 2021–2030 (USD Million)
Table 95 Europe: NGS Market, for Research Applications, by Type, 2021–2030 (USD Million)
Table 96 Europe: NGS Market, by End User, 2021–2030 (USD Million)
Table 97 Germany: Key Macro & Micro Indicators
Table 98 Germany: NGS Market, by Offering, 2021–2030 (USD Million)
Table 99 Germany: NGS Consumables Market, by Type, 2021–2030 (USD Million)
Table 100 Germany: NGS Sample Preparation Consumables Market, by Type, 2021–2030 (USD Million)
Table 101 Germany: NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 102 Germany: NGS Market, by Technology, 2021–2030 (USD Million)
Table 103 Germany: NGS Market, by Application, 2021–2030 (USD Million)
Table 104 Germany: NGS Market, for Clinical Applications, by Type, 2021–2030 (USD Million)
Table 105 Germany: NGS Market, for Research Applications, by Type, 2021–2030 (USD Million)
Table 106 Germany: NGS Market, by End User, 2021–2030 (USD Million)
Table 107 France: Key Macro & Indicators
Table 108 France: NGS Market, by Offering, 2021–2030 (USD Million)
Table 109 France: NGS Consumables Market, by Type, 2021–2030 (USD Million)
Table 110 France: NGS Sample Preparation Consumables Market, by Type, 2021–2030 (USD Million)
Table 111 France: NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 112 France: NGS Market, by Technology, 2021–2030 (USD Million)
Table 113 France: NGS Market, by Application, 2021–2030 (USD Million)
Table 114 France: NGS Market for Clinical Applications, by Type, 2021–2030 (USD Million)
Table 115 France: NGS Market for Research Applications, by Type, 2021–2030 (USD Million)
Table 116 France: NGS Market, by End User, 2021–2030 (USD Million)
Table 117 U.K.: Key Macro & Micro Indicators
Table 118 U.K.: NGS Market, by Offering, 2021–2030 (USD Million)
Table 119 U.K.: NGS Consumables Market, by Type, 2021–2030 (USD Million)
Table 120 U.K.: NGS Sample Preparation Consumables Market, by Type, 2021–2030 (USD Million)
Table 121 U.K.: NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 122 U.K.: NGS Market, by Technology, 2021–2030 (USD Million)
Table 123 U.K.: NGS Market, by Application, 2021–2030 (USD Million)
Table 124 U.K.: NGS Market for Clinical Applications, by Type, 2021–2030 (USD Million)
Table 125 U.K.: NGS Market for Research Applications, by Type, 2021–2030 (USD Million)
Table 126 U.K.: NGS Market, by End User, 2021–2030 (USD Million)
Table 127 Italy: Key Macro & Micro Indicators
Table 128 Italy: NGS Market, by Offering, 2021–2030 (USD Million)
Table 129 Italy: NGS Consumables Market, by Type, 2021–2030 (USD Million)
Table 130 Italy: NGS Sample Preparation Consumables Market, by Type, 2021–2030 (USD Million)
Table 131 Italy: NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 132 Italy: NGS Market, by Technology, 2021–2030 (USD Million)
Table 133 Italy: NGS Market, by Application, 2021–2030 (USD Million)
Table 134 Italy: NGS Market for Clinical Applications, by Type, 2021–2030 (USD Million)
Table 135 Italy: NGS Market for Research Applications, by Type, 2021–2030 (USD Million)
Table 136 Italy: NGS Market, by End User, 2021–2030 (USD Million)
Table 137 Spain: Key Macro & Micro Indicators
Table 138 Spain: NGS Market, by Offering, 2021–2030 (USD Million)
Table 139 Spain: NGS Consumables Market, by Type, 2021–2030 (USD Million)
Table 140 Spain: NGS Sample Preparation Consumables Market, 2021–2030 (USD Million)
Table 141 Spain: NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 142 Spain: NGS Market, by Technology, 2021–2030 (USD Million)
Table 143 Spain: NGS Market, by Application, 2021–2030 (USD Million)
Table 144 Spain: NGS Market for Clinical Applications, by Type, 2021–2030 (USD Million)
Table 145 Spain: NGS Market for Research Applications, by Type, 2021–2030 (USD Million)
Table 146 Spain: NGS Market, by End User, 2021–2030 (USD Million)
Table 147 Estimated Number of New Cancer Cases, by Country, 2020 Vs. 2030
Table 148 Rest of Europe: NGS Market, by Offering, 2021–2030 (USD Million)
Table 149 Rest of Europe: NGS Consumables Market, by Type, 2021–2030 (USD Million)
Table 150 Rest of Europe: NGS Sample Preparation Consumables Market, by Type, 2021–2030 (USD Million)
Table 151 Rest of Europe: NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 152 Rest of Europe: NGS Market, by Technology, 2021–2030 (USD Million)
Table 153 Rest of Europe: NGS Market, by Application, 2021–2030 (USD Million)
Table 154 Rest of Europe: NGS Market for Clinical Applications, by Type, 2021–2030 (USD Million)
Table 155 Rest of Europe: NGS Market for Research Applications, by Type, 2021–2030 (USD Million)
Table 156 Rest of Europe: NGS Market, by End User, 2021–2030 (USD Million)
Table 157 Asia-Pacific: NGS Market, by Country/Region, 2021–2030 (USD Million)
Table 158 Asia-Pacific: NGS Market, by Offering, 2021–2030 (USD Million)
Table 159 Asia-Pacific: NGS consumables market, by type, 2021–2030 (USD Million)
Table 160 Asia-Pacific: NGS Sample Preparation Consumables Market, by TYPE, 2021–2030 (USD Million)
Table 161 Asia-Pacific: NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 162 Asia-Pacific: NGS Market, by Technology, 2021–2030 (USD Million)
Table 163 Asia-Pacific: NGS Market, by Application, 2021–2030 (USD Million)
Table 164 Asia-Pacific: NGS Market for Clinical Applications, by Type, 2021–2030 (USD Million)
Table 165 Asia-Pacific: NGS Market for Research Applications, by Type, 2021–2030 (USD Million)
Table 166 Asia-Pacific: NGS Market, by End User, 2021–2030 (USD Million)
Table 167 China: Key Macro & Micro Indicators
Table 168 China: NGS Market, by Offering, 2021–2030 (USD Million)
Table 169 China: NGS Consumables Market, by Type, 2021–2030 (USD Million)
Table 170 China: NGS Sample Preparation Consumables Market, by Type, 2021–2030 (USD Million)
Table 171 China: NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 172 China: NGS Market, by Technology, 2021–2030 (USD Million)
Table 173 China: NGS Market, by Application, 2021–2030 (USD Million)
Table 174 China: NGS Market for Clinical Applications, by Type, 2021–2030 (USD Million)
Table 175 China: NGS Market for Research Applications, by Type, 2021–2030 (USD Million)
Table 176 China: NGS Market, by End User, 2021–2030 (USD Million)
Table 177 Japan: Key Macro & Micro Indicators
Table 178 Japan: NGS Market, by Offering, 2021–2030 (USD Million)
Table 179 Japan: NGS Consumables Market, by Type, 2021–2030 (USD Million)
Table 180 Japan: NGS Sample Preparation Consumables Market, by Type, 2021–2030 (USD Million)
Table 181 Japan: NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 182 Japan: NGS Market, by Technology, 2021–2030 (USD Million)
Table 183 Japan: NGS Market, by Application, 2021–2030 (USD Million)
Table 184 Japan: NGS Market for Clinical Applications, by Type, 2021–2030 (USD Million)
Table 185 Japan: NGS Market for Research Applications, by Type, 2021–2030 (USD Million)
Table 186 Japan: NGS Market, by End User, 2021–2030 (USD Million)
Table 187 India: Key Macro & Micro Indicators
Table 188 India: NGS Market, by Offering, 2021–2030 (USD Million)
Table 189 India: NGS consumables market, by Type, 2021–2030 (USD Million)
Table 190 India: NGS Sample Preparation Consumables Market, by Type, 2021–2030 (USD Million)
Table 191 India: NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 192 India: NGS Market, by Technology, 2021–2030 (USD Million)
Table 193 India: NGS Market, by Application, 2021–2030 (USD Million)
Table 194 India: NGS Market for Clinical Applications, by Type, 2021–2030 (USD Million)
Table 195 India: NGS Market for Research Applications, by Type, 2021–2030 (USD Million)
Table 196 India: NGS Market, by End User, 2021–2030 (USD Million)
Table 197 Estimated Number of New Cancer Cases, by Country, 2020 VS. 2030
Table 198 Rest of Asia-Pacific: NGS Market, by Offering, 2021–2030 (USD Million)
Table 199 Rest of Asia-Pacific: NGS Consumables Market, by Type, 2021–2030 (USD million)
Table 200 Rest of Asia-Pacific: NGS Sample Preparation Consumables Market, by Type, 2021–2030 (USD Million)
Table 201 Rest of Asia-Pacific: NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 202 Rest of Asia-Pacific: NGS Market, by Technology, 2021–2030 (USD Million)
Table 203 Rest of Asia-Pacific: NGS Market, by Application, 2021–2030 (USD Million)
Table 204 Rest of Asia-Pacific: NGS Market for Clinical Applications, by Type, 2021–2030 (USD Million)
Table 205 Rest of Asia-Pacific: NGS Market for Research Applications, by Type, 2021–2030 (USD Million)
Table 206 Rest of Asia-Pacific: NGS Market, by End User, 2021–2030 (USD Million)
Table 207 Latin America: NGS market size, by country, 2021–2030 (USD Million)
Table 208 Latin America: NGS Market, by Offering, 2021–2030 (USD Million)
Table 209 Latin America: NGS Consumables Market, by TYPE, 2021–2030 (USD Million)
Table 210 Latin America: NGS Sample Preparation Consumables Market, by Type, 2021–2030 (USD Million)
Table 211 Latin America: NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 212 Latin America: NGS Market, by Technology, 2021–2030 (USD Million)
Table 213 Latin America: NGS Market, by Application, 2021–2030 (USD Million)
Table 214 Latin America: NGS Market for Clinical Applications, by Type, 2021–2030 (USD Million)
Table 215 Latin America: NGS Market for Research Applications, by Type, 2021–2030 (USD Million)
Table 216 Latin America: NGS Market, by End User, 2021–2030 (USD Million)
Table 217 Brazil: Key Macro & Micro Indicators
Table 218 Brazil: NGS Market, by Offering, 2021–2030 (USD Million)
Table 219 Brazil: NGS Consumables Market, by Type, 2021–2030 (USD Million)
Table 220 Brazil: NGS Sample Preparation Consumables Market, by Type, 2021–2030 (USD Million)
Table 221 Brazil: NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 222 Brazil: NGS Market, by Technology, 2021–2030 (USD Million)
Table 223 Brazil: NGS Market, by Application, 2021–2030 (USD Million)
Table 224 Brazil: NGS Market for Clinical Applications, by Type, 2021–2030 (USD Million)
Table 225 Brazil: NGS Market for Research Applications, by Type, 2021–2030 (USD Million)
Table 226 Brazil: NGS Market, by End User, 2021–2030 (USD Million)
Table 227 Mexico: Key Macro & Micro Indicators
Table 228 Mexico: NGS Market, by Offering, 2021–2030 (USD Million)
Table 229 Mexico: NGS Consumables Market, by Type, 2021–2030 (USD Million)
Table 230 Mexico: NGS Sample Preparation Consumables Market, by Type, 2021–2030 (USD Million)
Table 231 Mexico: NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 232 Mexico: NGS Market, by Technology, 2021–2030 (USD Million)
Table 233 Mexico: NGS Market, by Application, 2021–2030 (USD Million)
Table 234 Mexico: NGS Market for Clinical Applications, by Type, 2021–2030 (USD Million)
Table 235 Mexico: NGS Market for Research Applications, by Type, 2021–2030 (USD Million)
Table 236 Mexico: NGS Market, by End User, 2021–2030 (USD Million)
Table 237 Rest of Latin America: NGS Market, by Offering, 2021–2030 (USD Million)
Table 238 Rest of Latin America: NGS Consumables Market, by Type, 2021–2030 (USD Million)
Table 239 Rest of Latin America: NGS Sample Preparation Consumables Market, by Type, 2021–2030 (USD Million)
Table 240 Rest of Latin America: NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 241 Rest of Latin America: NGS Market, by Technology, 2021–2030 (USD Million)
Table 242 Rest of Latin America: NGS Market, by Application, 2021–2030 (USD Million)
Table 243 Rest of Latin America: NGS Market for Clinical Applications, by Type, 2021–2030 (USD Million)
Table 244 Rest of Latin America: NGS Market for Research Applications, by Type, 2021–2030 (USD Million)
Table 245 Rest of Latin America: NGS Market, by End User, 2021–2030 (USD Million)
Table 246 Middle East & Africa: NGS Market, by Offering, 2021–2030 (USD Million)
Table 247 Middle East & Africa: NGS Consumables Market, by Type, 2021–2030 (USD Million)
Table 248 Middle East & Africa: NGS Sample Preparation Consumables Market, by Type, 2021–2030 (USD Million)
Table 249 Middle East & Africa: NGS Market, by Sequencing Type, 2021–2030 (USD Million)
Table 250 Middle East & Africa: NGS Market, by Technology, 2021–2030 (USD Million)
Table 251 Middle East & Africa: NGS Market, by Application, 2021–2030 (USD Million)
Table 252 Middle East & Africa: NGS Market for Clinical Applications, by Type, 2021–2030 (USD Million)
Table 253 Middle East & Africa: NGS Market for Research Applications, by Type, 2021–2030 (USD Million)
Table 254 Middle East & Africa: NGS Market, by End User, 2021–2030 (USD Million)
Table 255 Recent Developments, by Company, 2020-2023
Table 256 Applications & Methods of Thermofisher NGS Platforms/Instruments (Benchtop Sequencers)
Table 257 Features of Thermofisher NGS Platforms/ Instruments (Benchtop Sequencers)
Table 258 Specifications of Ion Proton System
Table 259 Illumina, Inc. (U.S.): NGS Systems Installed Base & New Installations in 2022
Table 260 Applications & Methods of Illumina NGS Platforms/Instruments (Benchtop Sequencers)
Table 261 Features of Illumina NGS Platforms/ Instruments (Benchtop Sequencers)
Table 262 Applications & Methods of Illumina NGS Platforms/Instruments (Production–Scale Sequencers)
Table 263 Features of Illumina NGS Platforms/ Instruments (Production–Scale Sequencers)
Table 264 Pacific Biosciences of California, Inc. (U.S.): NGS Systems Installed Base
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for this Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global NGS Market, by Offering, 2023 Vs. 2030 (USD Million)
Figure 8 Global NGS Market, by Sequencing Type, 2023 Vs. 2030 (USD Million)
Figure 9 Global NGS Market, by Technology, 2023 Vs. 2030 (USD Million)
Figure 10 Global NGS Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 11 Global NGS Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 12 Global NGS Market, by Geography, 2023 Vs. 2030 (USD Million)
Figure 13 Pharmaceutical R&D Expenditures in the U.S., Europe, and China, 2010 Vs. 2019 Vs. 2020 (USD Million)
Figure 14 Global Pharmaceutical R&D Expenditure, 2012–2026 (USD Billion)
Figure 15 Porter's Five Forces Analysis
Figure 16 USFDA Regulatory Pathways for IVD Kits
Figure 17 EU Regulatory Pathway - IVDR 2017/746
Figure 18 China: Medical Device Classification and Pre-Market Requirements for NGS Instruments
Figure 19 Global NGS Market, by Offering, 2023 Vs. 2030 (USD Million)
Figure 20 Steps of Sample Preparation in a Typical NGS Workflow
Figure 21 Global NGS Market, by Sequencing Type, 2023 Vs. 2030 (USD Million)
Figure 22 Global NGS Market, by Technology, 2023 Vs. 2030 (USD Million)
Figure 23 Global NGS Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 24 U.S.: New Molecular Entity (NME) Approvals
Figure 25 Estimated Number of New Cancer Cases (in Million)
Figure 26 Global NGS Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 27 Global NGS Market, by Geography, 2023 Vs. 2030 (USD Million)
Figure 28 North America: NGS Market Snapshot
Figure 29 U.S.: Pharmaceutical R&D Expenditure, 2014–2021 (USD Billion)
Figure 30 Europe: Pharmaceutical Industry R&D Expenditure (2000–2021)
Figure 31 Europe: NGS Market Snapshot
Figure 32 Italy: Number of Biotechnology Firms, 2010-2021
Figure 33 Roe: Pharmaceutical R&D Expenditure, 2020
Figure 34 Asia-Pacific: NGS Market Snapshot
Figure 35 Latin America: NGS Market Snapshot
Figure 36 Key Growth Strategies Adopted by Leading Players, 2020– 2023
Figure 37 Next Generation Sequencing (NGS) Market: Competitive Benchmarking by Offering
Figure 38 Next Generation Sequencing (NGS) Market: Competitive Benchmarking, by Region
Figure 39 Global Next Generation Sequencing (NGS) Market Share Analysis, by Key Players, 2022 (%)
Figure 40 Competitive Dashboard: Next Generation Sequencing (NGS) Market
Figure 41 Thermo Fisher Scientific, Inc.: Financial Overview (2022)
Figure 42 Illumina, Inc.: Financial Overview (2022)
Figure 43 Qiagen N.V.: Financial Overview (2022)
Figure 44 F. Hoffmann-La Roche Ltd: Financial Overview (2022)
Figure 45 PerkinElmer, Inc.: Financial Overview (2022)
Figure 46 Agilent Technologies, Inc.: Financial Overview (2022)
Figure 47 Pacific Biosciences of California, Inc.: Financial Overview (2022)
Figure 48 Danaher Corporation: Financial Overview (2022)
Figure 49 Bio-Rad Laboratories: Financial Overview (2022)
Figure 50 Oxford Nanopore Technologies Plc.: Financial Overview (2022)
Figure 51 10X Genomics, Inc.: Financial Overview (2022)
Figure 52 Beijing Genomics Institute (BGI): Financial Overview (2022)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
DNA Sequencing Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Aug-2024
Europe NGS Market - Opportunity Analysis and Industry Forecasts (2024-2030)
Published Date: Jul-2024
